{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:58:50Z","timestamp":1784282330641,"version":"3.55.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,7]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Pegylated interferon-alpha (PEG-IFN-\u03b1) is available for the treatment of hepatitis B virus infection, which is better than interferon-alpha (IFN-\u03b1) for the inhibition of hepatitis B virus replication. Ischemic colitis has been described from non-pegylated IFN-\u03b1, which occurs mainly in patients with hepatitis C virus infection. This is the first case of ischemic colitis during pegylated IFN-\u03b1 monotherapy for chronic hepatitis B.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 35-year-old Chinese man presented with complaints of acute lower abdominal pain and haematochezia, who was receiving PEG-IFN-\u03b1-2a monotherapy for chronic hepatitis B.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Colonoscopy revealed scattered ulcers and severe mucosal inflammation with edema in the left hemi colon and necrotizing changes in the descending portion. Biopsies revealed focal mucosal chronic inflammation and mucosal erosion. Therefore, the patient was diagnosed with ischemic colitis based on clinical and testing results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>PEG-IFN-\u03b1 therapy was discontinued and switched to symptomatic management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient was discharged from the hospital after recovery. Follow-up colonoscopy revealed normal. The temporal association between the resolution of ischemic colitis and cessation of PEG-IFN-\u03b1 treatment strongly favors the diagnosis of interferon-induced ischemic colitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Ischaemic colitis is a severe emergency complication of interferon therapy. Physicians should consider this complication in any patient taking PEG-IFN-\u03b1 who develops abdominal discomfort and hematochezia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033378","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T13:16:37Z","timestamp":1680873397000},"page":"e33378","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8711-294X","authenticated-orcid":false,"given":"Yu","family":"Liu","sequence":"first","affiliation":[{"name":"Intensive Care Unit, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ying","family":"Xu","sequence":"additional","affiliation":[{"name":"Internal Medicine Ward, Hunan Provincial People\u2019s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0016-5085(00)70183-1","article-title":"AGA technical review on intestinal ischemia. American gastrointestinal association.","volume":"118","author":"Brandt","year":"2000","journal-title":"Gastroenterology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1111\/j.1365-2893.2011.01501.x","article-title":"Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review.","volume":"19","author":"Kawaguchi","year":"2012","journal-title":"J Viral Hepat"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1345\/aph.1R526","article-title":"Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of th e literature.","volume":"47","author":"Salk","year":"2013","journal-title":"Ann Pharmacother"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3109\/00365521.2016.1162325","article-title":"Update on ischemic colitis: from etiopathology to treatment including patients of intensive care unit.","volume":"51","author":"Doulberis","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/00365520903513225","article-title":"Ischemic colitis in the elderly: predictors of the disease and prognostic factors to negative outcome.","volume":"45","author":"Mosele","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"R6-20250504","first-page":"955","article-title":"Interferon treatment of chronic hepatitis C-induced ischemic bowel disease: two case reports and a l iterature review.","volume":"22","author":"Wei","year":"2014","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"3S3s","DOI":"10.1592\/phco.23.9.3S.32886","article-title":"Pegylation: engineering improved biopharmaceuticals for oncology.","volume":"23","author":"Molineux","year":"2003","journal-title":"Pharmacotherapy"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1155\/2006\/687836","article-title":"Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.","volume":"20","author":"Leung","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1574-695X.2007.00217.x","article-title":"Vasculitis induced by immunization with Bacillus Calmette-Gu\u00e9rin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease.","volume":"49","author":"Nakamura","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R10-20250504","first-page":"403","article-title":"Two cases of rheumatoid arthritis complicated with vasculitis-induced ischemic enterocolitis.","volume":"30","author":"Okuda","year":"1990","journal-title":"Ryumachi"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1097-0142(19911001)68:7<1538::AID-CNCR2820680714>3.0.CO;2-2","article-title":"Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha.","volume":"68","author":"Sparano","year":"1991","journal-title":"Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF02989208","article-title":"Interferon-gamma, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver.","volume":"28 Suppl 5","author":"Morshed","year":"1993","journal-title":"Gastroenterol Jpn"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3748\/wjg.14.5980","article-title":"Fibrinogen-like protein 2\/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma.","volume":"14","author":"Su","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.CIR.90.2.694","article-title":"Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation.","volume":"90","author":"Vaddi","year":"1994","journal-title":"Circulation"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/BF02355061","article-title":"Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.","volume":"31","author":"Tada","year":"1996","journal-title":"J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:24:20Z","timestamp":1746325460000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":15,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033378","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,7]]}}}